The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

9676–9700 of 17987

  • SevereFDA (Drugs)·D-0709-2018·2018-05-09

    AuroMedics Recalls Levofloxacin IV Bags Due to Sterility Concerns

    AuroMedics Pharma LLC is recalling 308,112 bags of Levofloxacin in 5% Dextrose Injection due to a lack of assurance of sterility and a confirmed report of mold.

    Product
    LEVOFLOXACIN — LEVOFLOXACIN (LEVOFLOXACIN IN 5% DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0703-2018·2018-05-09

    AuroMedics Recalls Linezolid Injection Bags Due to Sterility Concerns

    AuroMedics Pharma LLC is recalling Linezolid Injection bags due to a lack of assurance of sterility and a confirmed report of leaking bags with mold.

    Product
    LINEZOLID — LINEZOLID (LINEZOLID)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0704-2018·2018-05-09

    AuroMedics Recalls Levofloxacin IV Bags Due to Sterility Concerns

    AuroMedics Pharma LLC is recalling specific lots of Levofloxacin in 5% Dextrose Injection due to a lack of assurance of sterility and a confirmed report of leaking bags with mold.

    Product
    LEVOFLOXACIN — LEVOFLOXACIN (LEVOFLOXACIN IN 5% DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0804-2018·2018-05-09

    Sanofi Recalls Over-Concentrated Docetaxel Injection Vials Nationwide

    Sanofi-Aventis is recalling 19,580 vials of Docetaxel injection concentrate due to potential over-concentration. The affected lots were distributed nationwide.

    Product
    DOCETAXEL — DOCETAXEL (DOCETAXEL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0706-2018·2018-05-09

    AuroMedics Recalls Levetiracetam Injection Due to Sterility Concerns

    AuroMedics Pharma LLC is recalling Levetiracetam Injection due to a lack of assurance of sterility and a confirmed report of leaking bags and mold.

    Product
    LEVETIRACETAM — LEVETIRACETAM (LEVETIRACETAM IN SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0710-2018·2018-05-09

    Rhodes Pharmaceuticals Recalls Aptensio XR Capsules Due to Dissolution Failure

    Rhodes Pharmaceuticals is recalling Aptensio XR capsules because they failed to meet dissolution specifications. The affected lot was distributed nationwide.

    Product
    Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0724-2018·2018-05-02

    Coastal Meds Recalls LIPO-PLEX Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling LIPO-PLEX Injectable-30 mL vials nationwide due to the presence of unknown particulate matter.

    Product
    LIPO-PLEX Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0699-2018·2018-05-02

    Premier Pharmacy Labs Recalls Morphine Sulfate Injection Due to Sterility Concerns

    Premier Pharmacy Labs is recalling specific lots of Morphine Sulfate Injection because routine testing of other lots detected microbial contamination risks.

    Product
    Morphine Sulfate 2 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-129-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0722-2018·2018-05-02

    FDA Recalls Lipoderm Extreme Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 3,733 vials of LIPO-DEN EXTREME Injectable-30 mL due to the presence of unknown particulate matter.

    Product
    LIPO-DEN EXTREME Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0701-2018·2018-05-02

    Premier Pharmacy Labs Recalls Hydromorphone Syringes Due to Sterility Concerns

    Premier Pharmacy Labs is recalling 3,570 hydromorphone syringes because routine testing of other lots found microbial contamination risks.

    Product
    Hydromorphone HCl 1 mg/mL PF INJ. 1mL in a 3mL Sterile Single-Dose Syringe. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-249-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0702-2018·2018-05-02

    Premier Pharmacy Labs Recalls NeoStigmine Syringes Due to Sterility Concerns

    Premier Pharmacy Labs is recalling NeoStigmine Methylsulfate syringes because routine testing of other lots detected microbial contamination risks.

    Product
    NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way Weeki Wachee, FL 34613 NDC 69623-234-14.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0719-2018·2018-05-02

    Coastal Meds Recalls Hydroxocobalamin Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 1,506 vials of Hydroxocobalamin Injectable due to the presence of unknown particulate matter. The product was distributed nationwide.

    Product
    HYDROXOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0697-2018·2018-05-02

    Bayer Recalls Alka-Seltzer Plus Packages Due to Ingredient Label Mismatch

    Bayer is recalling specific Alka-Seltzer Plus packages because the ingredients listed on the front sticker may not match the actual product inside the carton.

    Product
    All Alka-Seltzer Plus¿ packages with a full front panel instant Redeemable Coupon (IRC) affixed to the individual carton. The recalled products can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or g
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0718-2018·2018-05-02

    Coastal Meds Recalls ADENO-PLEX Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 200 vials of ADENO-PLEX Injectable-30 mL MDV due to the presence of unknown particulate matter.

    Product
    ADENO-PLEX Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0700-2018·2018-05-02

    Premier Pharmacy Labs Recalls Morphine Sulfate Syringes Due to Sterility Concerns

    Premier Pharmacy Labs Inc is recalling 4,192 syringes of Morphine Sulfate 4 mg/mL PF Injection due to a lack of assurance of sterility.

    Product
    Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-127-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0723-2018·2018-05-02

    Coastal Meds Recalls LIPO-DEN PLUS Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 1,457 vials of LIPO-DEN PLUS Injectable because of the presence of unknown particulate matter. The product was distributed nationwide in the USA.

    Product
    LIPO-DEN PLUS Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0726-2018·2018-05-02

    Coastal Meds Recalls Pyridoxine Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 635 vials of Pyridoxine Injectable due to the presence of unknown particulate matter.

    Product
    PYRIDOXINE Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0725-2018·2018-05-02

    Coastal Meds Recalls Methylcobalamin Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 4,524 vials of Methylcobalamin Injectable due to the presence of unknown particulate matter.

    Product
    METHYLCOBALAMIN Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0713-2018·2018-05-02

    Lyne Laboratories Recalls Subpotent Fluocinolone Acetonide Topical Oil

    Lyne Laboratories is recalling 23,453 units of Fluocinolone Acetonide Topical Oil because the product is subpotent. The recall is voluntary and classified as FDA Class II.

    Product
    FLUOCINOLONE ACETONIDE — FLUOCINOLONE ACETONIDE (FLUOCINOLONE ACETONIDE)
    Category
    Drug
    Distribution
    0 states
  • HighFDA (Drugs)·D-0720-2018·2018-05-02

    Coastal Meds Recalls LIPO-B Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling LIPO-B Injectable-30 mL vials due to the presence of unknown particulate matter.

    Product
    LIPO-B Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0717-2018·2018-05-02

    Coastal Meds Recalls Cyanocobalamin Injectable Due to Particulate Matter

    Coastal Meds, LLC. is recalling 745 vials of Cyanocobalamin Injectable due to the presence of unknown particulate matter.

    Product
    CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0721-2018·2018-05-02

    FDA Recalls LIPO-DEN Injectable Due to Unknown Particulate Matter

    Coastal Meds, LLC. is recalling 1,309 vials of LIPO-DEN Injectable-30 mL because of the presence of unknown particulate matter.

    Product
    LIPO-DEN Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0715-2018·2018-05-02

    McKesson Recalls Diltiazem CD Capsules Due to Dissolution Failures

    McKesson Packaging Services is recalling Diltiazem CD 180 mg capsules because stability testing showed high dissolution results.

    Product
    Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0693-2018·2018-05-02

    Time-Cap Recalls Ibuprofen Tablets Due to Odor Complaints

    Time-Cap Laboratories is recalling specific lots of 800 mg ibuprofen tablets due to odor complaints linked to CGMP deficiencies.

    Product
    Ibuprofen Tablets USP 800 mg, a) 100 tablet (NDC 42582-113-10) and b) 500 tablet (NDC 42582-113-18) bottles, Rx, Distributed by; Bi-Coastal Pharma International, Shrewsbury, NJ, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0695-2018·2018-05-02

    Time-Cap Recalls Ibuprofen Caplets Due to Odor Complaints

    Time-Cap Laboratories is recalling specific bottles of Ibuprofen 200 mg caplets due to odor complaints linked to CGMP deficiencies.

    Product
    IBUPROFEN — IBUPROFEN (IBUPROFEN)
    Category
    Drug
    Distribution
    Distributed nationwide